Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018

Details for Mechanism ID: 18212
Country/Region: Ukraine
Year: 2018
Main Partner: KNCV Tuberculosis Foundation
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $450,000 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $450,000
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST 25-29, Female, Negative 2019 338
HTS_TST 25-29, Male, Negative 2019 316
HTS_TST 30-34, Female, Negative 2019 338
HTS_TST 30-34, Male, Negative 2019 316
HTS_TST 35-39, Female, Negative 2019 338
HTS_TST 35-39, Male, Negative 2019 316
HTS_TST 40-49, Female, Negative 2019 338
HTS_TST 40-49, Male, Negative 2019 316
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 5,106
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 357
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 186
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 590
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 396
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 157
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 125
HTS_TST_POS 25-29, Female, Positive 2019 26
HTS_TST_POS 25-29, Male, Positive 2019 20
HTS_TST_POS 30-34, Female, Positive 2019 69
HTS_TST_POS 30-34, Male, Positive 2019 54
HTS_TST_POS 35-39, Female, Positive 2019 80
HTS_TST_POS 35-39, Male, Positive 2019 99
HTS_TST_POS 40-49, Female, Positive 2019 88
HTS_TST_POS 40-49, Male, Positive 2019 137
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 8
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 42
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 48
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 732
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 1,236
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 1,968
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 2,168
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 4,469
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 6,637
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 6,637
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 2,168
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 4,469